en
svPress releases
Regulatory press release 2026-05-12
Bulletin from the annual general meeting of Xspray Pharma AB (publ) 12 May 2026
Regulatory press release 2026-04-30
New number of shares and votes in Xspray Pharma after new share issue April 2026
Regulatory press release 2026-04-28
Interim Report First Quarter 2026
Regulatory press release 2026-04-23
Xspray’s rights issue oversubscribed – over-allotment issue fully utilized
Press release 2026-04-14
FDA accepts trade name Nilopki® for Xspray’s drug candidate XS003 (nilotinib)
-
Latest report
Interim Report Q1 2026 -
Subscribe
Get our latest press releases and reports
